Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07460349) titled 'Extended Interval Dosing of Gentamicin in Neonates' on Feb. 26.

Study Type: Observational

Primary Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Condition: Early Onset Sepsis

Intervention: Other: Standard of care administration of gentamicin dosed at 3 mg/kg every 24 hours

Recruitment Status: Not recruiting

Date of First Enrollment: March 2026

Target Sample Size: 42

Countries of Recruitment: Canada

To know more, visit https://clinicaltrials.gov/study/NCT07460349

Published by HT Digital Content Services with permission from Health Daily Digest....